[ Price : $8.95]
Novartis asks FDA not to approve ANDAs seeking to produce a generic form of its Entresto under specific conditions.[ Price : $8.95]
Federal Register Notice: FDA announces an 11/1 Advisory Committee meeting to discuss ongoing concerns that pulse oximeters may be ...[ Price : $8.95]
FDA associate commissioner Mark Abdoo calls for greater collaborative efforts worldwide to combat illicit trade in healthcare prod...[ Price : $8.95]
FDA says Baxter Healthcares recall of its Clearlink Basic Solution Sets with Duovent is Class 1.[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Intra-Cellular Therapies Ca...[ Price : $8.95]
FDA says the Anesthesiology and Respiratory Therapy Devices Panel will meet virtually on 11/1 to discuss issues of potential pulse...[ Price : $8.95]
FDA publishes an International Conference on Harmonization revised guidance on elemental impurities in drug products.[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Rigel Pharmaceuticals Taval...